Skip to search formSkip to main contentSkip to account menu

amfenac

Known as: 2-amino-3-benzoylbenzeneacetic acid, monosodium salt, monohydrate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Nepafenac ophthalmic suspension is a topical non-steroidal anti-inflammatory drug (NSAID) approved in the US and Europe for… 
2007
2007
Purpose: Nepafenac is a novel NSAID and a constituent of Nevanac® ophthalmic suspension. We characterized the inhibition kinetics… 
2005
2005
PurposeTo examine the effect of nepafenac, a selective cyclooxygenase-2 (COX-2) inhibitor, on the proliferation rate of two human… 
Review
2005
Review
2005
Since most non-steroidal anti-inflammatory drugs (NSAIDs) contain only one obvious ionisable group at physiological pH levels… 
1990
1990
A series of potential prodrugs of 2-amino-3-benzoylbenzeneacetic acid (amfenac) and 2-amino-3-(4-chlorobenzoyl)benzeneacetic acid… 
1988
1988
Amfenac Na is a new non-steroidal analgesic anti-inflammatory drug which is clinically used for ailments such as rheumatoid… 
1986
1986
Amfenac, an arylacetic acid derivative, is a new investigational, nonsteroidal antiinflammatory agent that has exhibited…